Online citations, reference lists, and bibliographies.
← Back to Search

Clinical Practice Guidelines.

J. Wootton
Published 1999 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Society for Vascular Surgery clinical practice guidelines evaluate the evidence in the scientific literature, assess the likely benefits and harms of a particular treatment, and enable healthcare providers to select the best care for a unique patient based on his or her preferences. The Society develops guidelines to aid its members and their patients in the decision-making process. SVS guideline writing groups draw upon systematic reviews of the available evidence to inform key recommendations. Systematic reviews and meta-analyses are performed by the Mayo Clinic Evidence-based Practice Center, in Rochester, Minnesota. The methodology used for SVS clinical practice guidelines has been published in the Journal of Vas??cular Surgery. SVS members are invited to propose guideline topics, using the request form .
This paper references
10.1016/0277-5379(89)90270-8
ChlVPP chemotherapy in advanced Hodgkin's disease.
J. Mckendrick (1989)
How to break bad news: interactional skills training manual for general practitioners, junior medial officers, nurses and surgeons
Girgis (1997)
10.1200/JCO.1998.16.5.1931
Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.
E. Sánchez (1998)
10.1001/ARCHDERM.134.8.1001
Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.
E. Fraser-Andrews (1998)
Manual of Diagnostic Antibodies for Immunohistology
E. Jones (1999)
10.1200/JCO.1995.13.2.359
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
A. Reiter (1995)
10.1200/JCO.1996.14.7.2131
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.
M. H. Kramer (1996)
10.7326/0003-4819-121-8-199410150-00007
Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome)
P. Bunn (1994)
10.1002/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z
Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
K. Seidemann (1999)
10.7326/0003-4819-126-4-199702150-00005
Use of Testosterone To Prevent Cyclophosphamide-Induced Azoospermia
A. Masala (1997)
10.1001/ARCHPSYC.1993.01820210015002
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.
F. Fawzy (1993)
10.3109/10428190009113383
Non-Hodgkin's Lymphoma Subtypes over Time in an Unselected Population of 646 Patients: A Study of Clinico-Pathological Data and Incidence Based on a Review Using the REAL-Classification
H. Brincker (2000)
10.1056/nejm199309303291402
A predictive model for aggressive non-Hodgkin's lymphoma.
M. Shipp (1993)
The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists.
(2000)
10.1038/sj.bmt.1702796
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
H. Lazarus (2001)
10.1016/S1083-8791(00)70021-8
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.
K. Stockerl-Goldstein (2000)
10.1016/S0002-9610(96)00217-6
Glutamine, cancer, and its therapy*
V. S. Klimberg (1996)
10.1016/S0190-9622(96)90282-0
Combined modality therapy for cutaneous T-cell lymphoma.
M. Duvic (1996)
10.1136/bmj.309.6947.86
Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment
S. M. Downer (1994)
10.1200/JCO.1999.17.4.1244
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
B. Cheson (1999)
10.1067/MJD.2000.108370
Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma?
H. Ständer (2000)
10.1002/(SICI)1097-0339(199908)21:2<98::AID-DC4>3.0.CO;2-V
Fine‐needle aspiration with flow cytometric immunophenotyping for primary diagnosis of intra‐abdominal lymphomas
K. Liu (1999)
10.1200/JCO.2001.19.16.3596
Treatment of Waldenstrom's macroglobulinemia with thalidomide.
M. Dimopoulos (2001)
10.1111/J.1445-5994.1995.TB01491.X
Writing to referring doctors after a new patient consultation. What is wanted and what was contained in letters from one medical oncologist?
M. Tattersall (1995)
Clinical Nutrition, 17: 195-198
A. M. Beck (1998)
10.1093/AJCP/101.5.555
Fine-needle aspiration and immunophenotyping. A role in diagnostic hematopathology?
C. A. Hanson (1994)
10.1053/CTRV.2000.0174
Breast cancer risk following irradiation for Hodgkin's disease.
M. Clemons (2000)
10.1093/OXFORDJOURNALS.ANNONC.A058107
Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol.
J. Sweetenham (1992)
10.1023/A:1008263226895
Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.
T. Gross (1998)
10.1182/BLOOD.V94.2.429.414K26_429_433
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
G. Jerusalem (1999)
10.1093/OXFORDJOURNALS.ANNONC.A058519
Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma.
U. Mueller (1993)
Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls.
B. L. Steel (1995)
10.2337/diacare.21.1.S23
Standards of Medical Care for Patients With Diabetes Mellitus
(1998)
Clinical presentation and outcome in lymphocytepredominant Hodgkin's disease
S Bodis (1997)
Lombardi non-Hodgkin's lymphomas
C Tondini (1993)
Culture and food choices
P Crotty (1981)
10.1016/S0899-9007(99)00232-4
Effect of dietary glutamate on chemotherapy-induced immunosuppression.
P. Fürst (2000)
Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis.
M. Meistrich (1999)
10.1002/1097-0142(197909)44:3<1155::AID-CNCR2820440354>3.0.CO;2-C
Atypical hyperplasia of lymph nodes A follow‐up study
K. Schroer (1979)
10.1002/1097-0142(20000801)89:3<647::AID-CNCR21>3.0.CO;2-R
Image‐guided core‐needle biopsy in patients with suspected or recurrent lymphomas
E. de Kerviler (2000)
10.1016/0959-8049(94)90064-7
Economic and clinical evaluation of therapy of HIV-related non-Hodgkin's lymphoma with chemotherapy and granulocyte colony-stimulating factor (G-CSF)
U. Tirelli (1994)
10.1038/sj.bmt.1702378
Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin’s lymphoma patients: a single centre study
S. Limat (2000)
10.1016/S0360-3016(98)00233-8
What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
M. M. Mac Manus (1998)
Non-Hodgkin's lymphoma time trends: United States and international data.
S. Devesa (1992)
10.1056/NEJM199605093341906
Non-Hodgkin's lymphoma in childhood.
J. Sandlund (1996)
10.3109/10428199909083390
Clinicopathological evaluation of the Revised European-American Classification of Lymphoid Neoplasms (REAL) in Japan.
K. Isobe (1999)
10.1200/JCO.1996.14.9.2431
Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable.
D. Ben-Yehuda (1996)
10.1200/JCO.1991.9.1.133
HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
M. Schwenn (1991)
10.1097/00007890-200010270-00021
CONVERSION TO RAPAMYCIN IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS: REPORT OF AN INITIAL EXPERIENCE1
J. Domínguez (2000)
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
M. Adde (1998)
10.1016/0167-8140(91)90023-A
Suprahyoid Hodgkin's disease stage IA.
E. Bessell (1991)
10.1200/JCO.1996.14.4.1252
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
W. Bowman (1996)
10.1200/JCO.1997.15.3.1118
Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.
A. Rueda (1997)
10.1182/BLOOD.V86.9.3333.BLOODJOURNAL8693333
Aggressive treatment for postcardiac transplant lymphoproliferation.
L. Swinnen (1995)
10.1200/JCO.1991.9.9.1580
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
E. Neuwelt (1991)
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
T. D. de Witte (1994)
10.1046/J.1440-1673.2000.00847.X
Mantle planning: report of the Australasian Radiation Oncology Lymphoma Group film survey and consensus guidelines.
M. Barton (2000)
10.1200/JCO.2001.19.11.2927
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingd
J. Sweetenham (2001)
10.1002/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T
Favorable prognosis after late relapse of hodgkin's disease
R. Garcia-Carbonero (1998)
10.1056/NEJM198805193182013
Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.
R. Shapiro (1988)
10.1093/ANNONC/11.SUPPL_1.S3
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
N. Harris (2000)
10.1200/JCO.1996.14.2.549
Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.
J. Rijlaarsdam (1996)
10.1164/AJRCCM.154.6.8970360
Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
R. Aris (1996)
10.1016/S1470-2045(00)00293-X
Unconventional therapies for cancer and cancer-related symptoms.
A. Vickers (2001)
10.1182/BLOOD.V95.2.416
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
A. Reiter (2000)
10.1097/00000478-200110000-00007
Progression to Large B-Cell Lymphoma in Splenic Marginal Zone Lymphoma: A Description of a Series of 12 Cases
F. Camacho (2001)
10.1016/S0889-8588(05)70469-X
Overview of treatment of localized low-grade lymphomas.
M. M. Mac Manus (1997)
10.1002/1097-0142(19831215)52:12<2214::AID-CNCR2820521207>3.0.CO;2-H
Ointment‐based mechlorethamine treatment for mycosis fungoides
N. Price (1983)
Overview of the epidemiology of malignancy in immune deficiency.
N. Mueller (1999)
10.1200/JCO.2000.18.15.2908
Primary cutaneous T-cell lymphoma: review and current concepts.
R. Siegel (2000)
10.1177/0148607199023003117
Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study.
P. Schloerb (1999)
10.1200/JCO.1998.16.5.1909
Emerging role of laparoscopy in the diagnosis of lymphoma.
G. B. Mann (1998)
10.1002/1097-0142(20001001)89:7<1586::AID-CNCR24>3.0.CO;2-1
Malignant lymphoma in southern Taiwan according to the revised European–American classification of lymphoid neoplasms
S. Chuang (2000)
10.1200/JCO.1996.14.9.2427
Role of image-guided core-needle biopsy in the management of patients with lymphoma.
V. Pappa (1996)
10.1097/00005792-199103000-00005
Epstein‐Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency
J. Cohen (1991)
10.3109/07357908509039813
Malignant lymphoma in patients with the Wiskott-Aldrich syndrome.
J. Cotelingam (1985)
10.1016/0360-3016(80)90027-9
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
S. Monfardini (1980)
10.1016/0167-8140(95)01600-L
Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma.
S. Pendlebury (1995)
10.1200/JCO.1994.12.6.1177
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
A. Rohatiner (1994)
10.1200/JCO.2001.19.2.389
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
J. Vose (2001)
10.1056/NEJM199305063281806
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.
O. Kamel (1993)
10.1001/ARCHINTE.158.21.2303
A review of the incorporation of complementary and alternative medicine by mainstream physicians.
J. Astin (1998)
10.3109/10428199509107906
Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma.
P. Zinzani (1995)
10.1177/0148607186010006558
Effects of resistive exercise on skeletal muscle in marrow transplant recipients receiving total parenteral nutrition.
B. Cunningham (1986)
Costs of introducing autologous BMT in the treatment of lymphoma and acute leukaemia in The Netherlands.
C. U. Uyl-de Groot (1995)
10.1016/S0889-8588(18)30061-3
Chemotherapy for mycosis fungoides and the Sézary syndrome.
S. Rosen (1995)
10.1007/s004320000178
Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up
U. Wollina (2001)
10.1016/0147-0272(90)90018-L
Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
R. Hoppe (1990)
10.1038/bjc.1996.169
Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?
A. Mcmichael (1996)
10.1182/BLOOD.V94.7.2208.419K21_2208_2216
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
R. Curtis (1999)
10.1200/JCO.2001.19.18.3861
Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.
P. Koch (2001)
10.1200/JCO.1999.17.2.706
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.
M. Hjermstad (1999)
10.3816/CLM.2001.N.009
Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.
C. Fiorani (2001)
10.1016/S0002-9610(00)00358-5
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.
K. Morris (2000)
10.1159/000331355
Cytodiagnosis of Lymphoid Proliferations by Fine Needle Aspiration Biopsy
E. Ravinsky (1999)
10.1046/j.1365-2133.2000.03286.x
Extracorporeal photopheresis in cutaneous T‐cell lymphoma. Inconsistent data underline the need for randomized studies
R. Russell-Jones (2000)
Management of paediatric lymphoma.
T. Philip (1996)
10.1093/ANNONC/5.SUPPL_2.S127
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
V. Zagonel (1994)
10.1097/00001648-199609000-00003
Drinking Water Nitrate and the Risk of Non‐Hodgkin's Lymphoma
M. Ward (1996)
10.1136/mp.53.4.194
Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction
M. Hoeve (2000)
10.1182/BLOOD.V89.2.601
Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.
W. Wilson (1997)
10.1200/JCO.1999.17.8.2471
Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
M. Bekkenk (1999)
10.1093/AJCP/94.3.338
Clonal immunoglobulin gene rearrangement in nodular lymphoid hyperplasia of the gastrointestinal tract associated with common variable immunodeficiency.
M. Laszewski (1990)
10.1056/NEJM199004263221701
Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy.
M. Link (1990)
Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma.
M. Osada (1999)
10.1002/(SICI)1097-0142(19970715)80:2<225::AID-CNCR9>3.0.CO;2-S
Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma
M. Kogon (1997)
10.1200/JCO.1989.7.11.1630
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
T. Lister (1989)
10.1002/(SICI)1097-0142(19960501)77:9<1912::AID-CNCR23>3.0.CO;2-1
Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T‐cell lymphoma treated with total skin electron beam radiation therapy
P. Quiros (1996)
Incidence and consequences of post-transplantation lymphoproliferative disorders.
S. Boubenider (1997)
Report on workshop: UICC workshop ‘Therapy of NHL in early stages’. Part 1: Follicular lymphoma
M Engelhard (2001)
Australian Institute of Health and Welfare. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare
C Mathers (1999)
10.1182/BLOOD.V91.8.2955.2955_2955_2960
The clinical significance of molecular response in indolent follicular lymphomas.
A. López-Guillermo (1998)
Canberra: Australian Institute of Health and Welfare, Australasian Association of Cancer Registries
(2000)
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
J. Armitage (1991)
10.1182/BLOOD.V97.12.3699
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
K. Seidemann (2001)
10.1080/01635588909514034
Dietary factors and non-Hodgkin's lymphoma: a case-control study in the northeastern part of Italy.
S. Franceschi (1989)
10.1056/NEJM199906033402206
Use of alternative medicine by women with early-stage breast cancer.
H. Burstein (1999)
Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
L. Molin (1981)
10.1097/00000478-199711000-00012
Are primary cutaneous immunocytoma and marginal zone lymphoma the same disease?
L. Duncan (1997)
10.1002/1097-0142(19930401)71:7<2335::AID-CNCR2820710727>3.0.CO;2-D
Cyclosporine treatment of refractory T‐cell lymphomas
D. Cooper (1993)
10.1002/1097-0142(19910601)67:11<2890::AID-CNCR2820671131>3.0.CO;2-W
Utility of molecular genetic analysis for the diagnosis of neoplasia in morphologically and immunophenotypically equivocal hematolymphoid lesions
R. Eric Davis (1991)
10.1002/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H
Reduction of tumor burden and stabilization of disease by systemic therapy with anti‐CD20 antibody (rituximab) in patients with primary cutaneous B‐cell lymphoma
L. Heinzerling (2000)
10.1182/BLOOD.V89.12.4514
Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
A. Melnyk (1997)
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
R. Walker (1995)
10.1084/JEM.184.4.1495
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
H. Kanzler (1996)
10.1023/A:1008399623564
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.
P. Brice (2000)
10.1200/JCO.2000.18.17.3144
Treatment for primary CNS lymphoma: the next step.
L. Abrey (2000)
10.1200/JCO.1988.6.5.813
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
J. Sanders (1988)
The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors.
M. Segar (1998)
10.1097/00007890-198743060-00012
Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation.
S. Weisdorf (1987)
10.1136/jcp.45.12.1105
Audit of bone marrow trephines.
P. Bishop (1992)
10.7326/0003-4819-96-1-130_2
Lymph node biopsy.
L. Dubilier (1979)
10.1200/JCO.1997.15.1.5
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
T. Smith (1997)
10.1093/HUMREP/15.9.1985
Follow-up of sperm concentration and motility in patients with lymphoma.
R. Tal (2000)
10.1016/0959-8049(95)00117-2
Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study.
F. Alexander (1995)
10.1200/JCO.1992.10.7.1078
Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.
P. Morel (1992)
10.1002/1097-0142(197808)42:2+<979::AID-CNCR2820420721>3.0.CO;2-S
The chemotherapy of Hodgkin's disease. Past experiences and future directions
V. DeVita (1978)
Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.
P. Bunn (1979)
10.1177/030089168407000410
Lymphoblastic Lymphoma in Adults: A Study on 30 Patients Treated with Two Different Programs According to Bone Marrow Findings
C. Bernasconi (1984)
Complementary and alternative cancer medicine.
B. Cassileth (1999)
10.1182/blood.v80.3.587.587
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
A. Saven (1992)
10.1016/S0959-8049(00)00327-0
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy.
S. Limat (2000)
10.1016/S0140-6736(95)91150-2
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
C. Rooney (1995)
10.7326/0003-4819-94-6-829_3
Hodgkin's and non-Hodgkin's lymphomas.
P. Hartge (1994)
10.1038/sj.leu.2401427
Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis
A. Langerak (1999)
10.1002/(SICI)1097-0142(19980825)84:4<252::AID-CNCR11>3.0.CO;2-R
Utilization of fine‐needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma
N. A. Young (1998)
10.1200/JCO.1996.14.11.3026
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
J. Sparano (1996)
10.1200/JCO.1993.11.11.2279
General information tapes inhibit recall of the cancer consultation.
S. Dunn (1993)
10.1200/JCO.1995.13.4.961
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
V. Leblond (1995)
10.1007/BF02953304
Hodgkin’s Disease
J. McGrath (1964)
10.1002/(SICI)1097-0142(19991225)87:6<325::AID-CNCR3>3.0.CO;2-W
Diagnosis of lymphoma by fine‐needle aspiration cytology using the revised European–American classification of lymphoid neoplasms
N. A. Young (1999)
10.1002/1097-0142(19850101)55:1+<273::AID-CNCR2820551312>3.0.CO;2-D
The impact of antitumor therapy on nutrition
W. Kokal (1985)
10.1359/jbmr.1999.14.3.342
Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation
P. Ebeling (1999)
10.1016/0360-3016(84)90028-2
Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience.
M. Gospodarowicz (1984)
10.1200/JCO.1992.10.4.644
Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission.
L. Verdonck (1992)
Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials.
H. Kaplan (1966)
10.3109/10428190109097655
Cost-Effectiveness of Interferon Alfa-2b Added to Chemotherapy for High-Tumor-Burden Follicular Non-Hodgkin's Lymphoma
D. Wirt (2001)
10.1093/JNCI/86.19.1450
Risk of leukemia following treatment for non-Hodgkin's lymphoma.
L. Travis (1994)
10.1016/S0360-3016(00)00780-X
Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University.
A. Murtha (2001)
Fine-needle aspiration cytology in the diagnosis of lymphoma. The next step.
L. Sandhaus (2000)
10.1182/BLOOD.V97.2.404
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
S. Horning (2001)
10.1002/1097-0142(20010715)92:2<218::AID-CNCR1312>3.0.CO;2-6
Expert review of the diagnosis and histologic classification of Hodgkin disease in a population‐based cancer registry
S. Glaser (2001)
10.1200/JCO.1994.12.6.1305
The take-home message: patients prefer consultation audiotapes to summary letters.
M. Tattersall (1994)
10.1056/NEJM199312093292419
Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
J. Andersen (1993)
10.1038/sj.bmt.1701554
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome
T G Gross (1999)
Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children.
E. Gerritsen (1996)
10.1093/ANNONC/11.SUPPL_1.S137
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
A. López-Guillermo (2000)
10.7326/0003-4819-120-11-199406010-00002
Low-Dose Involved Field Radiation after Chemotherapy in Advanced Hodgkin Disease: A Southwest Oncology Group Randomized Study
C. Fabian (1994)
10.1034/j.1399-3062.2001.003003177.x
Epstein–Barr virus post‐transplant lymphoproliferative disease and virus‐specific therapy: pharmacological re‐activation of viral target genes with arginine butyrate
S. Mentzer (2001)
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
T. Batiuk (1993)
10.1038/BJC.1976.15
Cancer Epidemiology and Prevention
J. Knowelden (1976)
10.3109/02841867709133941
Cerebrospinal irradiation of Burkitt's lymphoma. Failure in preventing central nervous system relapse.
C. Olweny (1977)
A meta-analysis (MA) of randomised trials evaluating the role of interferon (IFN) as treatment for follicular lymphoma (FL)
AZS Rohatiner (1998)
World Health Organization Classification of Tumours. Pathology and genetics of haemotopoietic and lymphoid tissues
(2001)
10.1200/JCO.1993.11.6.1024
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.
J. Anderson (1993)
10.1016/S1040-8428(88)80009-X
Effects of cancer treatment on the reproductive system.
W. Gradishar (1988)
10.1182/BLOOD.V85.4.1075.BLOODJOURNAL8541075
A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study.
R. Fisher (1995)
Natural history of and therapy for the indolent non-Hodgkin's lymphomas.
S. Horning (1993)
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
C. U. Uyl-de Groot (1995)
10.1093/ANNONC/11.SUPPL_1.S45
Diagnosis and treatment of transplant-related lymphoma.
L. Swinnen (2000)
The evolving science of pharmacogenetics: clinical and ethnic perspectives.
K M Lin (1996)
10.3109/10428199509051714
Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma.
G. Dranitsaris (1995)
Follicular (nodular) lymphoma in childhood: a rare clinicalpathological entity
G Frizzera (1979)
The antitumor effect of monoclonal anti-CD20 antibody therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma cell lines
D G Maloney (1996)
10.1177/014107689508800408
Is spiritual healing a valid and effective therapy?
R. Hodges (1995)
10.1200/JCO.2001.19.2.398
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
A. Sarris (2001)
10.1136/bmj.1.6112.533
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
T. Lister (1978)
10.1034/j.1399-3062.2001.003002108.x
Interferon and cytotoxic chemotherapy for the treatment of post‐transplant lymphoproliferative disorder
C. Davis (2001)
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
S. Zangwill (1998)
10.1200/JCO.2000.18.2.332
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
A. Josting (2000)
10.1016/S0360-3016(01)01798-9
Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial.
U. Rühl (2001)
10.1046/j.1365-2141.2001.02926.x
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
E. Vellenga (2001)
10.1002/(SICI)1096-911X(199701)28:1<15::AID-MPO4>3.0.CO;2-W
Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors.
D. Crom (1997)
10.1056/NEJM199407143310202
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
K. Offit (1994)
10.1182/BLOOD.V72.2.520.BLOODJOURNAL722520
Epstein-Barr virus lymphoproliferation after bone marrow transplantation.
M. Zutter (1988)
10.1016/S0190-9622(99)70491-3
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
H. Zackheim (1999)
10.1016/S0140-6736(00)03571-6
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
H. Liu (2001)
10.1200/JCO.1998.16.3.864
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
J. Blay (1998)
Glutamate ameliorates experimental vincristine neuropathy.
F. Boyle (1996)
10.1002/1097-0142(19810101)47:1<1::AID-CNCR2820470102>3.0.CO;2-2
The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture
V. DeVita (1981)
10.1200/JCO.1986.4.5.805
Psychosocial problems among survivors of Hodgkin's disease.
P. Fobair (1986)
Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
M. Mihalov (1996)
10.1001/ARCHPSYC.58.5.494
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.
C. Classen (2001)
10.1111/J.1445-5994.1978.TB04518.X
Testicular damage due to cytotoxic drugs and recovery after cessation of therapy.
H. Roeser (1978)
10.1046/j.1365-2141.1997.d01-2010.x
Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972–92
D. J. van Spronsen (1997)
Non-Hodgkin's lymphoma.
A. Skarin (1989)
10.1200/JCO.1997.15.3.1123
Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies.
M. Torrey (1997)
10.1200/JCO.1984.2.7.841
The role of radiation therapy in the management of stage III follicular lymphomas.
S. Paryani (1984)
10.1200/JCO.1998.16.1.13
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
A. Freedman (1998)
10.1002/(SICI)1097-0339(199612)15:5<382::AID-DC5>3.0.CO;2-E
Fine‐needle aspiration cytology in the diagnosis of superficial lymphadenopathy: An analysis of 2,418 cases
R. R. Prasad (1996)
Pathology and genetics of haematopoietic and lymphoid tissues
(2001)
High-grade lymphoma 253
Lineage-specific differences in outcome for advanced large cell lymphoma in children and adolescents: results of a randomized phase III POG trial
J Laven (2001)
10.1016/S0140-6736(89)91551-1
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
D. Spiegel (1989)
Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
H. Prince (2001)
10.1111/j.1432-2277.2000.tb02070.x
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein‐Barr virus (EBV) infection
A. Buda (2000)
10.1200/JCO.2000.18.21.3622
Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
M. Mamzer-Bruneel (2000)
10.1182/BLOOD.V98.9.2640
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
V. Leblond (2001)
10.1148/RADIOLOGY.160.3.3737899
Hodgkin disease: contributions of chest CT in the initial staging evaluation.
R. Castellino (1986)
10.1002/1097-0142(19850315)55:6<1190::AID-CNCR2820550609>3.0.CO;2-6
Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer
I. Fleming (1985)
10.1002/(SICI)1097-0142(19970501)79:9<1717::AID-CNCR12>3.0.CO;2-0
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation
F. Dimeo (1997)
10.1016/0145-2126(89)90168-9
The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study.
S. Franceschi (1989)
10.1016/S0360-3016(98)00517-3
Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
D. Chinn (1999)
10.1200/JCO.1994.12.5.1063
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
F. V. van Leeuwen (1994)
10.1046/j.1365-2559.2001.01196.x
CD10 and Bcl10 expression in diffuse large B‐cell lymphoma: CD10 is a marker of improved prognosis
K. Ohshima (2001)
10.1001/JAMA.1997.03540420016005
Online support group helps patients live with, learn more about the rare skin cancer CTCL-MF.
L. Lamberg (1997)
10.1200/JCO.1992.10.11.1674
Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.
J. Yahalom (1992)
10.1001/ARCHDERM.135.1.26
Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
Y. Kim (1999)
10.1056/NEJM199301283280406
Unconventional medicine in the United States. Prevalence, costs, and patterns of use.
D. Eisenberg (1993)
Lymphadenopathy in a family practice: a descriptive study of 249 cases.
Williamson Ha (1985)
10.1093/neuonc/2.1.40
High-dose methotrexate for primary CNS lymphoma in the elderly.
S. Ng (2000)
10.1182/BLOOD.V94.3.902.415K23_902_908
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.
A. Rook (1999)
10.1182/blood.v95.12.3653.012k23_3653_3661
Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
M. Bekkenk (2000)
10.1016/S0360-3016(97)00352-0
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
A. Wirth (1997)
10.1093/ANNONC/11.SUPPL_1.S113
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
N. Milpied (2000)
Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T-cell lymphoma (CTCL)
H K Koh (1994)
10.1007/978-3-319-25586-6_11
Waldenström's macroglobulinemia.
M. Dimopoulos (1999)
10.1023/A:1008278605751
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma.
N. Ketterer (1997)
10.3892/OR.8.6.1393
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.
H. Dittmann (2001)
10.1093/ABM/15.4.245
Benefits of Psychological Preparation for Surgery: a Meta-Analysis
M. Johnston (1993)
10.1182/BLOOD.V98.13.3857
Autologous stem cell transplantation for HIV-associated lymphoma.
A. Krishnan (2001)
10.1182/BLOOD.V91.4.1178
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
K. van Besien (1998)
10.1046/J.1523-1747.2000.00830.X
Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides.
E. Fraser-Andrews (2000)
10.1093/AJCP/96.6.746
Immunoglobulin gene rearrangement in abnormal lymph node hyperplasia.
M. Williams (1991)
10.1093/JNCI/87.7.524
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.
L. Travis (1995)
10.1200/JCO.1998.16.12.3810
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
V. Diehl (1998)
10.1182/blood.v95.12.3922.012k08_3922_3928
Primary cutaneous follicle center cell lymphoma with follicular growth pattern.
L. Cerroni (2000)
10.1006/CLIM.1999.4725
Common variable immunodeficiency: clinical and immunological features of 248 patients.
C. Cunningham-Rundles (1999)
10.1182/BLOOD.V87.9.3625.BLOODJOURNAL8793625
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
P. Mauch (1996)
10.1002/PON.2960040102
A randomized controlled trial of preoperative psychological preparation for mastectomy
M. V. Burton (1995)
10.1200/JCO.1996.14.3.925
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
I. Magrath (1996)
10.1023/A:1008265532487
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.
J. Anderson (1998)
10.1111/j.1365-2559.1994.tb01284.x
The bone marrow trephine biopsy
P. Bishop (1994)
Malignant pelvic lymphomas.
J. Lathrop (1967)
10.1016/S0959-8049(99)00117-3
Paediatric Hodgkin's disease.
R. Poetter (1999)
10.1002/1097-0339(200102)24:2<90::AID-DC1017>3.0.CO;2-J
Cytology and immunophenotyping of low‐ and intermediate‐grade B‐cell non‐Hodgkin's lymphomas with a predominant small‐cell component: A study of 56 cases
D. Chhieng (2001)
10.1182/BLOOD.V97.3.616
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.
C. Moskowitz (2001)
10.1016/S0022-5347(01)62330-9
A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
T. Mathew (1998)
10.1111/j.1600-0609.1988.tb00232.x
Short‐term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma
R. Willemze (1988)
10.1111/j.1365-2141.1989.tb00224.x
Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission
N. Milpied (1989)
10.1177/088453369801300205
Success Using PEG Tubes in Marrow Transplant Recipients
Susan Roberts (1998)
10.1038/sj.leu.2401854
Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma
F. Bertolini (2000)
10.1016/0140-6736(91)91782-P
Letters to patients: improving communication in cancer care
D. Damian (1991)
Childhood malignant non-Hodgkin lymphomas of uncommon histology.
R. Ribeiro (1992)
10.1200/JCO.2000.18.13.2603
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
P. Zinzani (2000)
10.1200/JCO.1994.12.12.2588
The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.
J. Mercieca (1994)
Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.
J. L. Smith (1989)
10.1073/PNAS.080068597
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
M. Majewski (2000)
10.1097/00019606-199906000-00004
Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms.
M. Födinger (1999)
10.1034/j.1399-3046.2000.00083.x
Sirolimus in pediatric gastrointestinal transplantation: The use of sirolimus for pediatric transplant patients with tacrolimus‐related cardiomyopathy
P. A. Pappas (2000)
Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program.
D. Szeluga (1987)
10.5555/URI:PII:0740257092900314
The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
N. Harris (1992)
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
B. Younes (2000)
10.1093/ANNONC/9.SUPPL_5.S67
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
V. Diehl (1998)
10.1001/JAMA.286.12.1490
Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm.
K. Oktay (2001)
10.1182/blood.v96.4.1280
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group.
A. Josting (2000)
10.1097/00007890-198804000-00011
THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN
M. Ho (1988)
10.1023/A:1008350208019
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity.
J. Byrd (1999)
10.1037/0022-006X.54.5.616
Psychological adjustment to survival from Hodgkin's disease.
D. Cella (1986)
10.1038/sj.bmt.1701317
Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation
P. Anderson (1998)
10.1179/JOC.1999.11.1.54
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
E. Castagnola (1999)
10.1097/00007890-198902000-00020
INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONE
A. Wilkinson (1989)
10.1056/NEJM199107183250301
Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence.
D. Green (1991)
10.1016/0009-8981(91)90247-A
Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders.
J. V. van Dongen (1991)
10.1182/BLOOD.V90.1.354.354_354_371
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
R. Willemze (1997)
10.1200/JCO.2000.18.13.2505
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.
M. Richardson (2000)
Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial.
T. Kuchler (1999)
10.7326/0003-4819-129-12-199812150-00011
The Persuasive Appeal of Alternative Medicine
T. Kaptchuk (1998)
10.1093/OXFORDJOURNALS.ANNONC.A058768
The quality of life of long-term survivors of Hodgkin's disease.
M. V. van Tulder (1994)
Hodgkin's disease. Treatment sequelae and quality of life.
M. Henry-Amar (1996)
Unconventional therapies for cancer: a refuge from the rules of evidence?
I. Tannock (1998)
10.1182/BLOOD.V92.10.3591
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.
L. Brugières (1998)
10.1097/00008469-199510000-00008
The origins of Hodgkin's disease.
K. Michels (1995)
10.1016/S1084-8592(99)80036-8
Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases.
A. Krafft (1999)
10.1182/BLOOD.V92.6.1927.418K32_1927_1932
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
B. Coiffier (1998)
10.3109/10428190009053541
Untreated Aggressive Mantle Cell Lymphoma: Results with Intensive Chemotherapy without Stem Cell Transplant in Elderly Patients
J. Romaguera (2000)
10.1016/S0190-9622(98)70597-3
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
E. Vonderheid (1998)
10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O
The prevalence of complementary/Alternative medicine in cancer
Edzard Ernst (1998)
10.1200/JCO.1990.8.2.356
The effect of compliance with treatment on survival among patients with hematologic malignancies.
J. Richardson (1990)
10.1200/JCO.1998.16.7.2339
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.
B. Cole (1998)
10.1182/blood.v92.9.3137
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.
M. Benkerrou (1998)
10.1038/bjc.1990.100
Milk consumption and cancer incidence: a Norwegian prospective study.
G. Ursin (1990)
10.1182/BLOOD.V57.4.679.679
Lymphoblastic lymphoma in adults: results of a pilot protocol.
C. Coleman (1981)
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal Bcell proliferation
D W Hanto (1982)
Cancers after cyclosporine therapy.
I. Penn (1988)
10.1111/j.1349-7006.2000.tb00952.x
Practical Utility of the Revised European‐American Classification of Lymphoid Neoplasms for Japanese Non‐Hodgkin's Lymphomas
T. Izumo (2000)
The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.
G. Frizzera (1999)
10.1016/S0046-8177(00)80233-6
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin.
E. Roggero (2000)
10.1055/b-0034-75106
[ON THE LYMPH NODES].
I. Törö (1964)
10.1093/JNCI/89.18.1350
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
A. Neubauer (1997)
Lymphoma--histopathology in changing clinical perspective. Non-Hodgkin's Lymphoma Classification Project.
P. Jacobs (2000)
10.1007/S11912-000-0094-9
Epstein-Barr virus and hodgkin’s disease
L. Weiss (2000)
10.1111/1523-1747.EP12875523
Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
H. Roenigk (1990)
Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
I. Sadek (2000)
10.1309/0Q7F-QTGM-6DPD-TLGY
Diagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry.
B. A. Meda (2000)
10.1200/JCO.1996.14.6.1943
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
E. Salloum (1996)
Evidence for an orderly progression in the spread of Hodgkin's disease.
S. Rosenberg (1966)
10.3109/10428199909145953
Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.
U. Kaiser (1999)
10.1016/S0360-3016(00)00628-3
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
Z. Liao (2000)
10.1038/bjc.1994.380
Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS.
P. M. Carli (1994)
10.1002/MPO.1132
Thyroid cancer after radiotherapy for childhood cancer.
P. Inskip (2001)
10.1200/JCO.1998.16.1.338
Current perspectives on radiation-induced breast cancer.
P. Goss (1998)
10.1038/sj.bmt.1701104
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs
C. Tarella (1998)
10.1038/modpathol.3880232
PCR Analysis of Immunoglobulin Heavy Chain (IgH) and TcR-γ Chain Gene Rearrangements in the Diagnosis of Lymphoproliferative Disorders: Results of a Study of 525 Cases
C. Thériault (2000)
10.1054/bjoc.2001.1822
A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma
A. Rohatiner (2001)
10.1016/S0002-9343(96)00450-0
Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study.
D. R. Fleming (1997)
A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis.
O. Kamel (1999)
10.1056/NEJM198912283212603
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
F. Kaye (1989)
10.1210/JCEM.84.6.5802
Androgen replacement in women: a commentary.
S. Davis (1999)
10.1016/S0889-8588(18)30058-3
Electron beam treatment for cutaneous T-cell lymphoma.
G. Jones (1995)
10.1148/RADIOLOGY.169.1.3420256
Hodgkin disease: clinical utility of CT in initial staging and treatment.
K. Hopper (1988)
Australian gastronomy and the study of nutrition
B Santich (1981)
10.1016/S0360-3016(99)00051-6
The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
S. Kamath (1999)
10.1309/84VG-PL1V-T547-VC2R
Comparison of lymphoid neoplasm classification. A blinded study between a community and an academic setting.
J. Siebert (2001)
10.1007/978-3-642-85851-2
Cancer Incidence in Five Continents
Freddie Ian Bray (1970)
Technical factors in the preparation and evaluation of lymph node biopsies
P M Banks (1992)
New approach to classifying no Project
J O Armitage (1998)
Full-term pregnancy with embryos from donated oocytes in a 36-year-old woman allografted for chronic myeloid leukemia.
B. Rio (1994)
10.3109/10428199609067586
Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy?
I. Magrath (1996)
10.1097/00007890-199307000-00016
POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTS: CLINICAL EXPERIENCE AND RISK FACTOR ANALYSIS IN A SINGLE CENTER
Sandra M. Cockfield (1993)
10.1200/JCO.1998.16.2.536
Second cancers following pediatric Hodgkin's disease.
S. Wolden (1998)
10.1182/blood.v71.5.1234.1234
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.
R. Shapiro (1988)
10.1016/S0140-6736(01)05482-4
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey
N. Salooja (2001)
10.1002/1097-0339(200101)24:1<1::AID-DC1000>3.0.CO;2-J
Diagnosis of hematopoietic processes by fine‐needle aspiration in conjunction with flow cytometry: A review of 127 cases
K. Liu (2001)
Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.
J. Brumbaugh (1985)
10.1200/JCO.1994.12.2.312
Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
F. V. van Leeuwen (1994)
10.1111/j.1365-2133.1991.tb14772.x
The treatment of 45 patients with cutaneous T‐cell lymphoma with low doses of interferon‐α2a and etretinate
B. Dréno (1991)
10.1177/109980040100200304
Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise
S. Al-Majid (2001)
10.1046/j.1365-2141.2000.01918.x
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil
R. Kyle (2000)
10.1200/JCO.1997.15.4.1631
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
M. Janíček (1997)
10.1007/978-3-642-57054-4_14
Primary gastric lymphoma: brief overview of the recent Princess Margaret Hospital experience.
M. Gospodarowicz (2000)
10.1182/BLOOD.V87.7.3045.BLOODJOURNAL8773045
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
J. Sanders (1996)
10.1016/0046-8177(94)90295-X
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression.
O. Kamel (1994)
10.1182/BLOOD.V98.13.3595
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
I. Khouri (2001)
10.1001/JAMA.1989.03430190077035
Marriage and divorce after childhood and adolescent cancer.
J. Byrne (1989)
10.1016/S0145-2126(98)80012-X
Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire.
R. Cartwright (1988)
10.1016/S0140-6736(83)90435-X
TREATMENT OF MYCOSIS FUNGOIDES WITH ISOTRETINOIN
M. Alexander (1983)
10.1038/sj.leu.2401710
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes
F. Lefrère (2000)
10.7326/0003-4819-131-2-199907200-00003
Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial
G. Steinbach (1999)
10.1177/155335060000700208
Laparoscopic Interventions in Lymphoma Management
A. Lefor (2000)
10.1136/BMJ.319.7213.836
Users and practitioners of complementary medicine
C. Zollman (1999)
10.1200/JCO.1993.11.2.233
Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results.
J. Jacobs (1993)
10.1136/jech.53.6.383
Non-Hodgkin's lymphoma and nitrate in drinking water: a study in Yorkshire, United Kingdom.
G. Law (1999)
Follicular lymphomas in pediatric patients.
A. Pinto (1990)
10.7326/0003-4819-104-6-739
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
G. Bonadonna (1986)
10.1002/(SICI)1099-1611(199911/12)8:6<474::AID-PON427>3.0.CO;2-A
Effects of group CBT on the survival time of patients with metastatic breast cancer
S. Edelman (1999)
10.1016/0002-9343(82)90102-4
Treatment of life-threatening Epstein-Barr virus infection with acyclovir.
J. Sullivan (1982)
10.1200/JCO.1986.4.4.480
High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma.
G. Phillips (1986)
10.1016/S0360-3016(96)00277-5
High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.
J. Poen (1996)
10.1182/BLOOD.V90.9.3390
Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy.
F. Dimeo (1997)
10.1200/JCO.1984.2.7.762
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
W. Tester (1984)
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
M. Nalesnik (1988)
10.1097/00019606-199406000-00005
Detection of T‐Cell Clonality in Paraffin‐Embedded Tissues
J. Lorenzen (1994)
10.1002/LT.500050310
Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
Z. Ben‐Ari (1999)
10.1093/OXFORDJOURNALS.QJMED.A068614
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival.
D. Wright (1991)
10.1111/j.1365-2303.1994.tb00424.x
Hodgkin's disease: diagnostic accuracy of fine needle aspiration; a report based on 62 consecutive cases
F. Fulciniti (1994)
10.1097/00000478-198810000-00004
Antigen Preservation in Infarcted Lymphoid Tissue: A Novel Approach to the Infarcted Lymph Node Using Monoclonal Antibodies Effective in Routinely Processed Tissues
A. Norton (1988)
10.1054/bjoc.2000.1566
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
A. Messori (2001)
10.1200/JCO.1989.7.5.583
Telling the diagnosis of cancer.
S. Lind (1989)
10.1016/0360-3016(94)90102-3
Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy.
L. Wilson (1994)
10.1093/AJCP/109.6.682
Improved detection of CD5 epitope in formalin-fixed paraffin-embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval.
J. Butmarc (1998)
10.1002/PATH.1711690303
Detection of monoclonality in low‐grade B‐cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type
T. Diss (1993)
10.1016/S0140-6736(00)02041-9
High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma
J. Gabarre (2000)
10.1002/(SICI)1097-0142(19980601)82:11<2282::AID-CNCR26>3.0.CO;2-P
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non‐hodgkin's lymphoma
R. Nair (1998)
10.1007/S001470050677
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
H. Ekberg (2000)
10.1016/S0025-7125(16)31030-6
The relationship between nutrition, infection, and immunity.
L. Corman (1985)
Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
L. Molin (1987)
10.1002/(SICI)1097-0142(19990501)85:9<1985::AID-CNCR16>3.0.CO;2-O
Total skin electron radiation for patients with erythrodermic cutaneous T‐cell lymphoma (mycosis fungoides and the Sézary syndrome)
G. Jones (1999)
10.1016/0360-3016(94)90353-0
Salvage of relapse of patients with Hodgkin's disease in clinical stages I or II who were staged with laparotomy and initially treated with radiotherapy alone. A report from the international database on Hodgkin's disease.
L. Specht (1994)
10.1023/A:1008347425795
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.
B. Coiffier (1999)
10.1200/JCO.1995.13.10.2524
Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.
P. Hammel (1995)
10.3109/10428199609054867
Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients.
P. Zinzani (1996)
10.1093/ANNONC/5.SUPPL_2.S67
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden.
E. Kimby (1994)
10.1038/bjc.1997.19
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
A. Swerdlow (1997)
Fine needle aspiration diagnosis of malignant lymphoma with confirmation by immunoperoxidase staining.
S. Levitt (1985)
10.1002/PON.522
A comparison of Portuguese and American patients with hematological malignancies: a cross‐cultural survey of health‐related quality of life
M. J. Forjaz (2001)
Commentary on 'Cutaneous manifestations of lymphoma: a guide based on the WHO classification
R Willemze (2001)
10.1200/JCO.2001.19.16.3602
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
F. Grange (2001)
10.1016/S0022-3476(97)70131-8
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
K. Newell (1997)
10.1016/S0190-9622(94)70019-2
Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies.
R. el-Azhary (1994)
Rituximab therapy of lymphoproliferative disorders in immunosuppressed patients
A J Grillo-Lopez (1999)
Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term lowdose methotrexate therapy
O W Kamel (1996)
10.1016/0190-9622(91)70036-2
Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids.
R. Knobler (1991)
Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides.
H. Zachariae (1982)
10.1016/B978-044306901-7.50018-3
Immunoglobulin and T-cell receptor gene rearrangement.
J. Gill (1994)
10.1038/sj.leu.2401693
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report
J. Laver (2000)
Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis.
R. Thomason (1996)
Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor).
D. Smithers (1971)
10.1200/JCO.1988.6.4.588
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia.
E. D. Kreuser (1988)
10.1016/S0140-6736(00)04335-X
Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma
J. Radford (2001)
10.1001/ARCHPEDI.1987.04460060044029
The psychological status of survivors of childhood/adolescent Hodgkin's disease.
A. Wasserman (1987)
Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
G. Rothe (1996)
10.1378/CHEST.116.5.1273
A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.
S. Levine (1999)
10.1016/S0885-3924(00)00144-5
High level of fatigue in lymphoma patients treated with high dose therapy.
H. Knobel (2000)
10.1097/00007890-200109150-00017
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
G. Bumgardner (2001)
10.1182/blood.v91.3.984
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.
R. Siebert (1998)
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.
G. Canellos (1975)
10.1016/S0889-8588(05)70473-1
Treatment of organ transplant-related lymphoma.
L. Swinnen (1997)
Fine needle aspiration cytodiagnosis of Hodgkin's disease and its subtypes. I. Scope and limitations.
D. Das (1990)
10.1136/jcp.40.12.1472
Vitamin B12 absorption after allogeneic bone marrow transplantation.
D. Milligan (1987)
10.1097/00004583-199007000-00020
The influence of culture on pain in Anglo and Hispanic children with cancer.
B. Pfefferbaum (1990)
10.1200/JCO.1998.16.3.830
Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.
L. Specht (1998)
10.1182/blood.v47.5.747.747
Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial.
C. Portlock (1976)
10.1016/0140-6736(93)91409-F
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
A. Wotherspoon (1993)
10.1016/S1092-9134(99)80021-5
Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
J. Elgin (1999)
10.1016/0360-3016(94)90103-1
Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY.
G. Jones (1994)
10.1182/BLOOD.V89.3.801
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
S. Horning (1997)
10.1182/BLOOD.V88.9.3626.BLOODJOURNAL8893626
Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.
M. Hanson (1996)
10.1200/JCO.1996.14.4.1297
Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
A. Hirsch (1996)
10.1182/blood.v73.1.47.47
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
M. Tubiana (1989)
10.1016/S1055-3207(18)30474-5
Retroperitoneal masses, adenopathy, and adrenal glands.
F. Storm (1995)
10.1182/BLOOD.V92.10.3578.422K28_3578_3581
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
R. Stadler (1998)
10.1016/S0140-6736(83)90717-1
ISOTRETINOIN IN CUTANEOUS T-CELL LYMPHOMA
R. Warrell (1983)
10.1007/s003300050991
CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma
M. Sklair-Levy (2000)
10.1055/S-2007-973015
Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients.
D. Nieman (1995)
Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
K. Yeh (1997)
Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer.
V. Mock (1997)
10.1016/S0140-6736(76)91957-7
LYMPHOMAS AND ANIMAL-PROTEIN CONSUMPTION
S. Garwicz (1976)
The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
(1997)
Molecular and cytogenetic studies -diagnostic applications References 1. World Health Organization Classification of Tumours. Pathology and genetics of haematopoietic and lymphoid tissues
(2001)
CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial
M T Miller (2001)
10.1007/s100670170112
Methotrexate-Treated Arthritis and Lymphoproliferative Disease – Coincidence Only?
Y. Braun-Moscovici (2001)
10.1056/NEJM196009222631202
Treatment of Waldenstrom's macroglobulinemia by plasmapheresis.
P. J. Schwab (1960)
10.1200/JCO.1996.14.4.1291
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
N. Milpied (1996)
10.1182/BLOOD.V98.10.2930
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
M. Weihrauch (2001)
10.1111/j.1600-0609.1997.tb00956.x
Infradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience
K. M. Kälkner (1997)
How to compare the costs and benefits: evaluation of the economic evidence
K. Gerard (2001)
10.1046/J.1365-2559.1999.00721.X
Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
S. Lee (1999)
10.1164/AJRCCM.161.4.9901013
High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis.
A. H. Cohen (2000)
Nutritional factors and the development of non-Hodgkin's lymphoma: a review of the evidence.
S. Davis (1992)
10.1038/sj.bmt.1700642
Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin’s lymphoma
A. Messori (1997)
10.1182/BLOOD.V92.4.1150.416K04_1150_1159
Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
E. Diamandidou (1998)
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
R. C. Young (1988)
10.1097/00007890-199711270-00011
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
E. Sokal (1997)
10.1200/JCO.1997.15.11.3347
Successful pregnancy after allogeneic bone marrow transplant with embryos isolated before transplant.
J. Lipton (1997)
10.1097/00006842-198305000-00007
Brief Cognitive and Relaxation Training Increases Tolerance for a Painful Clinical Electromyographic Examination
R. Kaplan (1983)
10.1097/00007890-199705150-00002
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.
M. Nalesnik (1997)
10.1182/BLOOD.V98.5.1332
Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants.
A. Lemoine (2001)
10.1093/LABMED/16.8.468
Achieving Technical Excellence in Lymph Node Specimens: An Update
C. M. Beard (1985)
10.1001/ARCHINTE.1987.00370030133026
The effect of isotretinoin in six patients with cutaneous T-cell lymphoma.
S. Neely (1987)
10.1111/j.1440-0960.1997.tb01018.x
Mycosis fungoides: An Australian experience
A. Yen (1997)
10.1002/(SICI)1097-0142(19960615)77:12<2630::AID-CNCR29>3.0.CO;2-S
When the diagnosis is cancer: Patient communication experiences and preferences
P. Butow (1996)
10.1086/514142
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.
R. Máñez (1997)
10.1043/0003-9985(1999)123<1189:OOTROM>2.0.CO;2
Overview of the role of molecular methods in the diagnosis of malignant lymphomas.
L. J. Medeiros (1999)
10.1200/JCO.2001.19.9.2456
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.
M. Duvic (2001)
10.1097/00008469-199407000-00008
Coffee consumption and risk of non‐Hodgkin's lymphoma
A. Tavani (1994)
10.1111/j.1440-1797.1996.tb00076.x
Lymphoproliferative disorder post renal transplantation: Recent experience at a single centre
Eugenia Pedagogos (1996)
10.1200/JCO.1995.13.1.140
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.
P. Johnson (1995)
10.1093/ANNONC/8.SUPPL_1.S111
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Cu
J. Raemaekers (1997)
10.1200/JCO.1996.14.4.1282
Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
M. M. Mac Manus (1996)
Lymphadenopathy: differential diagnosis and evaluation.
R. Ferrer (1998)
Costs of high-dose salvage therapy and blood stem cell transplantation for resistant-relapsed malignant lymphomas in a southern Italian hospital.
P. Mazza (1999)
10.1016/0360-3016(84)90655-2
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
S. Rosenberg (1985)
10.7326/0003-4819-92-5-587
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
V. DeVita (1980)
Clinical intestinal transplantation: new perspectives and immunologic considerations.
K. Abu-Elmagd (1998)
10.1002/LT.500020508
Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.
A. Badley (1996)
10.1056/NEJM199710303371802
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
M. Link (1997)
10.1001/JAMA.1992.03490220063029
Misconceptions about cancer among Latinos and Anglos.
E. Pérez-Stable (1992)
10.1002/AJH.2830180112
Cancer and malnutrition—A critical interaction: A review
L. Balducci (1985)
10.1016/S1053-4296(96)80015-4
Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.
Cosset (1996)
10.1016/0378-5122(95)00991-4
The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation.
C. Castelo-Branco (1996)
Primary immunodeficiencies: genetic risk factors for lymphoma.
A. Filipovich (1992)
10.1136/BMJ.295.6604.955
Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.
J. Devlen (1987)
10.1038/NG0597-74
Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm
W. Robbins (1997)
10.1056/NEJM199706053362304
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
L. Kaplan (1997)
10.1200/JCO.1999.17.1.230
Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.
A. Wirth (1999)
10.1016/0277-5379(91)90017-8
Testicular dysfunction in Hodgkin's disease before and after treatment.
S. Viviani (1991)
10.1016/S0959-8049(01)00198-8
Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.
M. van Agthoven (2001)
Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy.
J. Baro (1992)
10.1097/00000478-199706000-00019
Marginal zone lymphoma of skin.
D. Slater (1997)
10.1016/0959-8049(95)00655-9
Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantation.
E. Souêtre (1996)
10.1017/S0266462399015317
Using appropriate comparisons in economic evaluations. An exercise in Belgium.
O. Van Tiggelen (1999)
10.1006/PMED.1994.1061
Smoking habits and non-Hodgkin's lymphoma: a case-control study in northern Italy.
A. Tavani (1994)
10.1016/0002-9343(81)90205-9
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease.
R. Schilsky (1981)
10.1016/0041-008X(86)90247-4
Cyclophosphamide in the seminal fluid of treated males: transmission to females by mating and effect on pregnancy outcome.
B. Hales (1986)
10.3109/10428199909145954
Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
O. Shpilberg (1999)
10.1182/blood.v61.1.92.92
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
A. Levine (1983)
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial.
B. Luce (1994)
10.1016/S0190-9622(96)90683-0
Photopheresis therapy for cutaneous T-cell lymphoma.
M. Duvic (1996)
10.1016/S0749-2081(98)80010-7
Lymphomas: long-term sequelae and survivorship issues.
J. Fernsler (1998)
10.1093/OXFORDJOURNALS.ANNONC.A059214
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
L. Jost (1995)
10.1200/JCO.2001.19.9.2439
Determinants of the use of complementary therapies by patients with cancer.
O. Paltiel (2001)
10.1182/BLOOD.V92.5.1832.417A04_1832_1836
Allogeneic bone marrow transplantation for low-grade lymphoma.
K. V. van Besien (1998)
10.1038/sj.bmt.1702695
Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)
A. Grigg (2000)
10.1159/000239590
Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
A. Pession (1997)
10.1016/S0167-8140(84)80072-9
Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial.
P. Carde (1984)
A cost-evaluation of glutaminesupplemented parenteral nutrition in adult bone marrow transplant patients
M Macburney (1994)
10.1093/ANNONC/5.SUPPL_2.S117
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.
B. Hancock (1994)
10.1043/0003-9985(1999)123<0068:PFTEOS>2.0.CO;2
Protocol for the examination of specimens from patients with non-Hodgkin's lymphoma: a basis for checklists. Cancer Committee, College of American Pathologists.
C. Compton (1999)
10.1016/0277-5379(88)90053-3
Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy.
E. Salloum (1988)
10.1200/JCO.2001.19.2.376
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
E. Olsen (2001)
10.1097/00126334-199905010-00111
TREATMENT OF HIV-RELATED NON-HODGKIN'S LYMPHOMA ADAPTED TO PROGNOSTIC FACTORS.
U. Tirelli (1999)
10.1093/JNCI/90.10.750
Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma.
C. Rubino (1998)
10.1182/BLOOD.V95.7.2212
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases
B. Vergier (2000)
10.1016/0190-9622(95)90241-4
Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
J. Herrmann (1995)
10.1002/(SICI)1097-0339(200002)22:2<120::AID-DC14>3.0.CO;2-8
Fine‐needle aspiration cytopathology in diagnosis and classification of malignant lymphoma: Accurate and reliable?
P. Wakely (2000)
10.1016/0277-5379(85)90088-4
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
S. Viviani (1985)
10.1182/blood.v57.1.186.186
The chemotherapy of lymphoblastic lymphoma.
J. Voakes (1981)
10.1093/ANNONC/8.SUPPL_2.S29
Primary B-cell lymphomas of the skin.
H. Kerl (1997)
10.1007/s100240010122
Pediatric Core Needle Biopsy: Strengths and Limitations in Evaluation of Masses
J. Willman (2001)
10.1093/JNCI/88.3-4.209
Re: Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk.
F. V. van Leeuwen (1996)
Human immunodeficiency virus-associated Hodgkin's disease.
M. Spina (2000)
10.1146/ANNUREV.ME.39.020188.000431
Tumors of the immunocompromised patient.
I. Penn (1988)
10.1016/0190-9622(90)70054-L
Sézary syndrome: diagnosis, prognosis, and critical review of treatment options.
J. S. Wieselthier (1990)
10.1093/ANNONC/9.SUPPL_5.S97
Primary refractory Hodgkin's disease.
S. Horning (1998)
10.1200/JCO.1998.16.8.2780
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.
J. Armitage (1998)
10.1182/BLOOD.V82.7.1994.BLOODJOURNAL8271994
p53 mutation is associated with progression in follicular lymphomas.
C. Sander (1993)
10.1002/(SICI)1096-9896(199906)188:2<146::AID-PATH334>3.0.CO;2-7
Clonal T‐cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in advanced cutaneous T‐cell lymphoma: a critical evaluation
E. Dippel (1999)
10.1093/ANNONC/5.SUPPL_2.S107
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
E. Noordijk (1994)
10.1182/BLOOD.V98.4.945
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
I. Lossos (2001)
10.1016/0190-9622(92)70212-X
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
P. Heald (1992)
10.1046/J.1365-2257.1999.00214.X
Quality control of flow cytometric immunophenotyping of haematological malignancies.
J. Gratama (1999)
Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
G. Starkebaum (2001)
10.1016/0046-8177(92)90134-O
Spectrum of morphologic changes in lymph nodes attributable to fine needle aspiration.
W. Tsang (1992)
10.1056/NEJM199603213341201
Breast cancer and other second neoplasms after childhood Hodgkin's disease.
S. Bhatia (1996)
Nutrition as an adjunct to cancer treatment in the adult.
E. Copeland (1977)
10.1097/00000478-199807000-00010
Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.
K. E. Salhany (1998)
10.1056/NEJM199108293250902
Thyroid diseases after treatment of Hodgkin's disease.
S. Hancock (1991)
10.1182/BLOOD.V92.1.76.413A19_76_82
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
C. Gisselbrecht (1998)
10.1136/jcp.51.3.189
Fine needle aspiration cytology in the investigation on non-Hodgkin's lymphoma.
M. Jeffers (1998)
10.1007/BF03262050
Detection of Clonal T-cell Receptor γ Gene Rearrangements Using Fluorescent-based PCR and Automated High-resolution Capillary Electrophoresis
V. Luo (2001)
10.1006/CLIM.2000.4994
Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome.
J. Duplantier (2001)
10.1200/JCO.1985.3.6.769
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.
E. Ezdinli (1985)
10.1093/ANNONC/11.SUPPL_1.S17
Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L./WHO Classification.
E. Jaffe (2000)
10.1038/bjc.1998.216
Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
S. Lee (1998)
Non-Hodgkin's lymphoma: pathogenesis, clinical presentation and treatement
K Cohen (2001)
Lymphomas associated with infection by the human immune deficiency virus (HIV)
M Raphael (2001)
Attitudes and practices of families of children in treatment for cancer. A cross-cultural study.
D. Copeland (1983)
10.1002/HON.2900080105
Treatment of low‐grade non‐Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trial
E. Lepage (1990)
10.1002/HON.660
The new World Health Organization classification of lymphomas: the past, the present and the future
J. Chan (2001)
10.2165/00019053-199610010-00004
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costs.
C. U. Uyl-de Groot (1996)
10.1159/000331354
FNAC of Malignant Lymphoma in an Area with a High Incidence of T-cell Lymphoma
In Ae Park (1999)
10.1093/OXFORDJOURNALS.HUMREP.A138181
Potential genetic risks of using semen collected during chemotherapy.
M. Meistrich (1993)
10.1182/BLOOD.V83.6.1460.BLOODJOURNAL8361460
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
T. Miller (1994)
10.1097/00042560-199804010-00142
Immunodeficiency-associated lymphoproliferative disorders.
D. Knowles (1999)
Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.
A. Faro (1998)
10.1182/BLOOD.V87.9.3633.BLOODJOURNAL8793633
Malignant neoplasms following bone marrow transplantation.
S. Bhatia (1996)
10.1200/JCO.1998.16.1.41
Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
A. Hagenbeek (1998)
10.1309/02M7-5JCC-YRTK-MGDR
T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently labeled PCR products.
J. Sprouse (2000)
Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
A. Filipovich (1994)
10.1046/J.1365-2168.1998.00774.X
Surgical endoscopic techniques in the diagnosis and follow‐up of patients with lymphoma
D. Gossot (1998)
10.1038/bjc.1994.213
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
B. Vaughan Hudson (1994)
10.1200/JCO.1993.11.8.1553
Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.
T. Facon (1993)
10.7326/0003-4819-112-8-636_3
Principles and Practice of Pediatric Oncology
P. Pizzo (1989)
10.1016/0738-3991(87)90107-8
Effects of contact between cancer patients on their psychosocial problems.
H. W. van den Borne (1992)
10.1016/0140-6736(93)92411-L
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
D. Linch (1993)
10.1200/JCO.1996.14.9.2444
Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study.
F. Joly (1996)
10.1200/JCO.1992.10.11.1662
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective.
C. Shapiro (1992)
The cultural context of death rituals and mourning practices.
M. Kagawa-Singer (1998)
10.1093/ANNONC/3.SUPPL_4.S117
Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
M. Henry-Amar (1992)
10.1054/MODI.2001.26157
Commentary: minimal residual disease: how low do we go?
A. Bagg (2001)
Developing an Active Australia: A framework for action for physical activity and health
(1998)
Immunodeficiency related lymphoma 295
References 1. National Health and Medical Research Council (NHMRC) guide to the development, implementation, and evaluation of clinical practice guidelines
(1998)
References 1. Eskinazi DP. Factors that shape alternative medicine
B R Cassileth (1989)
10.1200/JCO.1987.5.11.1796
Mycosis fungoides: management with topical nitrogen mustard.
R. Hoppe (1987)
10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B
Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy
F. Dimeo (1999)
10.1038/sj.bmt.1700998
Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin’s lymphoma patients
Mc. Woronoff-Lemsi (1997)
10.1001/ARCHFAMI.7.6.523
A review of 12 commonly used medicinal herbs.
M. Ohara (1998)
10.1002/PON.2960010304
Remembering ‘bad news’ consultations: An evaluation of tape‐recorded consultations
B. Hogbin (1992)
10.1111/j.1365-2141.1991.tb04417.x
Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases
S. Mulligan (1991)
10.1080/00029157.1995.10403160
The use of hypnosis in helping cancer patients control anxiety, pain, and emesis: a review of recent empirical studies.
M. Genuis (1995)
10.1016/S0140-6736(84)90994-2
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
T. Starzl (1984)
Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
M. Behrend (1999)
Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
T. M. Dawson (2001)
10.1182/BLOOD.V94.10.3325.422K13_3325_3333
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
A. Freedman (1999)
10.1200/JCO.1988.6.10.1576
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
P. Mauch (1988)
Supportive nutrition to prevent cachexia and improve quality of life.
F. Ottery (1995)
10.1016/S0959-8049(96)00518-7
Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone.
A. Horwich (1997)
10.1097/00002030-200111090-00007
Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery
C. Hoffmann (2001)
10.1023/A:1008418727472
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
A. López-Guillermo (1998)
Phase II trial of 2-chlordeoxyadenosine for the treatment of cutaneous T-cell lymphoma
T M Kuzel (1996)
10.1097/00000421-199204000-00005
Total Skin Electron Beam Radiation Therapy for Mycosis Fungoides
S. Reddy (1992)
10.1148/RADIOLOGY.210.2.R99FE07487
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
D. Front (1999)
10.1200/JCO.1995.13.1.257
Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
T. Kuzel (1995)
Lymphomatoid papulosis: a follow-up study of 41 patients.
H. Christensen (1994)
Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
D. Pariente (1992)
10.1182/BLOOD.V95.6.1950
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.
F. Berger (2000)
10.1517/14656566.2.6.929
Nucleoside analogues in the treatment of haematological malignancies
S. Johnson (2001)
Cancer cachexia: prevention, early diagnosis, and management.
F. Ottery (1994)
10.1016/S0959-8049(97)10096-X
What causes Hodgkin's disease in children?
C. Stiller (1998)
10.1056/NEJMOA011871
The effect of group psychosocial support on survival in metastatic breast cancer.
P. Goodwin (2001)
10.1046/j.1365-2141.2001.03041.x
Chimaeric anti‐CD20 monoclonal antibody (rituximab) in post‐transplant B‐lymphoproliferative disorder following stem cell transplantation in children
A. Faye (2001)
10.1016/S0190-9622(89)70049-9
Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.
E. Olsen (1989)
10.1093/OXFORDJOURNALS.HUMREP.A019467
Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients.
J. Shaw (1996)
10.1200/JCO.2000.18.1.214
Waldenström's macroglobulinemia: clinical features, complications, and management.
M. Dimopoulos (2000)
10.3109/10428190109057974
Reversal of Fludarabine Induced Testicular Damage in a Patient with Chronic Lymphocytic Leukaemia (CLL), by Suppression of Pituitary-Testicular Axis Using Gonadotrophin Releasing Hormone (GnRH)
R. Chatterjee (2001)
10.1097/00000478-199711000-00005
Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
L. Cerroni (1997)
10.7326/0003-4819-92-2-159
Anatomic substages of stage III-A Hodgkin's disease. A collaborative study.
R. Stein (1980)
10.1093/AJCP/92.2.177
The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients.
P. Randhawa (1989)
10.1200/JCO.1998.16.6.2052
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
V. Leblond (1998)
10.1093/AJCP/100.5.534
Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.
M. Borowitz (1993)
10.1097/00007890-200109270-00006
PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2
H. J. Wagner (2001)
10.1200/JCO.2000.18.10.2010
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
R. Fisher (2000)
10.1182/blood.v69.3.841.841
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma.
G. Schechter (1987)
10.1097/00125480-199603030-00006
Assessment of B-Cell Clonality by the Polymerase Chain Reaction: A Pragmatic Overview
G. H. Segal (1996)
10.1016/0167-8140(96)01779-3
Multicentre dosimetry study of mantle treatment in Australia and New Zealand.
C. Amies (1996)
10.1200/JCO.1999.17.8.2461
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
D. Thomas (1999)
Establishing the diagnosis of lymphoma: from initial biopsy to clinical staging.
R. Gascoyne (1998)
10.1016/S0360-3016(01)01747-3
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
R. Wilder (2001)
10.1007/978-3-642-83781-4_17
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
G. Bonadonna (1989)
10.1093/JNCI/91.20.1751
Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women.
S. Zhang (1999)
10.1073/PNAS.96.18.10391
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.
R. Khanna (1999)
Excessive toxicity is not seen with low-dose chemotherapy for HIV-associated non-Hodgkin's lymphoma (HIV-NHL) in combination with highly active antiretroviral therapy (HAART)
D Straus (1998)
Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosaassociated lymphoid tissue B-cell lymphoma
C Thiede (2001)
10.1016/S0140-6736(72)90502-8
Sterility and cyclophosphamide.
P. Uldall (1972)
10.1016/0360-3016(79)90481-4
Megavolt electron irradiation for localized mycosis fungoides.
T. C. Lo (1981)
10.1200/JCO.2001.19.23.4314
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma.
G. Akpek (2001)
10.1136/bmj.312.7039.1128
Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales
G. Bentham (1996)
10.1182/BLOOD.V98.1.194
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S. Straus (2001)
10.1182/blood.v90.8.2863
Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.
C. D. Jennings (1997)
10.1093/AJCP/104.2.126
Surgical pathology examination of lymph nodes. Practice survey by American Society of Clinical Pathologists.
J. Cousar (1995)
10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I
Superiority of adriamycin‐containing combination chemotherapy in the treatment of diffuse lymphoma. A southwest oncology group study
S. Jones (1979)
10.1007/s005209900057
Unproven methods in cancer: a worldwide problem
S. Schraub (2000)
10.1200/JCO.1998.16.7.2332
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
P. Solal-Céligny (1998)
10.1093/JNCI/87.20.1530
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
F. V. van Leeuwen (1995)
10.3109/10428199909093726
Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers.
D. Meirow (1999)
10.1200/JCO.1995.13.2.403
Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.
R. Munker (1995)
Vitamin E--its status and role in leukemia and lymphoma.
J. Dasgupta (1993)
10.1038/sj.bmt.1701142
Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin’s and non-Hodgkin’s lymphoma
K. Schulman (1998)
10.1016/S0140-6736(96)91271-4
Prevalence and cost of alternative medicine in Australia
A. MacLennan (1996)
10.1002/AJH.1102
Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project
Dennis D. Weisenburger (2001)
10.1016/S0049-0172(97)80023-6
Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.
L. Georgescu (1997)
10.1002/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E
Second cancers following non‐Hodgkin's lymphoma
L. Travis (1991)
10.1034/j.1399-0012.2000.140406.x
Usefulness of quantitative real‐time polymerase chain reaction in following up patients with Epstein–Barr virus infection after liver transplantation
T. Orii (2000)
10.1097/00007890-199912270-00006
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
R. Shapiro (1999)
Marrow transplantation for non-Hodgkin's lymphoma: a multi-centre study from the European Co-operative Bone Marrow Transplant Group.
P. Ernst (1986)
10.1097/00007890-200104270-00012
REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1
D. Tsai (2001)
10.1182/BLOOD.V96.2.640.014K31_640_646
High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing.
C. Assaf (2000)
10.1093/ANNONC/MDI820
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma.
L. Jost (2001)
10.5694/j.1326-5377.1994.tb127359.x
The use of alternative therapies by children with cancer
Michael G Sawyer (1994)
10.1016/S0025-6196(12)65716-4
Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions
C. F. Anderson (1989)
10.1002/(SICI)1097-0339(199910)21:4<240::AID-DC3>3.0.CO;2-Z
Value and limitations of fine‐needle aspiration cytology in diagnosis and classification of lymphomas: A review
D. Das (1999)
10.1016/0046-8177(94)90084-1
Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type.
G. Segal (1994)
10.1016/S1525-1578(10)60664-2
Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples.
D. Arber (2001)
Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness.
C. Faucher (1994)
10.1016/0360-3016(95)00180-7
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
A. Mundt (1995)
Canadian Editors. Canadian Fundamentals of Nursing 2nd edition
J. Ross-Kerr (2001)
Acyclovir therapy of Epstein-Barr virus induced posttransplant lymphoproliferative disease
D W Hanto (1985)
10.1182/BLOOD.V90.1.244
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
R. Gascoyne (1997)
10.1002/HEP.510300314
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation
C. Hézode (1999)
10.1002/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma. Results of a prospective randomized study
J. Yahalom (1993)
Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
N. Buskard (1977)
10.1016/0360-3016(89)90013-8
Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function.
L. M. Smith (1989)
10.1093/JNCI/85.23.1932
Second cancers among long-term survivors of non-Hodgkin's lymphoma.
L. Travis (1993)
Diffuse large B-cell lymphom
M A Shipp
Immunodeficiency related lymphoma 291
10.1056/NEJM199012203232502
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
L. Swinnen (1990)
10.1097/00005537-200106000-00013
Adenotonsillar Hypertrophy and Epstein‐Barr Virus in Pediatric Organ Transplant Recipients
N. Shapiro (2001)
10.1016/S0046-8177(79)80107-0
Preparations of lymph node biopsy specimens.
P. Banks (1979)
10.1200/JCO.1997.15.3.1110
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
P. Brice (1997)
10.1016/0738-3991(89)90047-5
Effects of preparatory information of a myelogram on patients' expectations and anxiety levels.
B. Flam (1989)
10.5694/j.1326-5377.1996.tb138639.x
Patterns of alternative medicine use by cancer patients
S. Begbie (1996)
Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy.
S. O'Brien (1997)
10.5555/URI:PII:0740257085900097
Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates.
J. Burke (1985)
10.1001/JAMA.280.18.1569
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.
D. Eisenberg (1998)
10.1016/S1525-1578(10)60636-8
Molecular diagnostic approach to non-Hodgkin's lymphoma.
D. Arber (2000)
10.1093/OXFORDJOURNALS.ANNONC.A010720
Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center.
P. Soubeyran (1996)
10.1002/(SICI)1099-1611(199811/12)7:6<508::AID-PON376>3.0.CO;2-7
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer
A. Cunningham (1998)
10.1097/00007890-199805131-00180
Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
K. McLaughlin (1998)
10.1001/ARCHDERM.136.4.504
Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.
R. V. van Doorn (2000)
10.1002/MPO.2950200204
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
C. Patte (1992)
10.1080/08858199209528187
Knowledge, attitudes, and practices of breast and cervical cancer screening among Vietnamese women.
C. T. Pham (1992)
10.1200/JCO.2000.18.12.2435
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
C. Metayer (2000)
10.1200/jco.2000.18.10.2152
Primary cutaneous B-cell lymphoma: review and current concepts.
T. Pandolfino (2000)
10.1054/bjoc.1999.0880
The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
S. Beard (2000)
10.2165/00002018-199920060-00002
Lymphoma in Patients with Rheumatoid Arthritis
L. Georgescu (1999)
10.1200/JCO.1993.11.2.239
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
R. M. Pryzant (1993)
10.1097/00007890-199110000-00033
Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis.
Y. Lien (1991)
10.1093/ANNONC/11.SUPPL_1.S23
Follicular lymphoma: have we made any progress?
S. Horning (2000)
10.1002/1097-0142(19921015)70:8<2214::AID-CNCR2820700833>3.0.CO;2-X
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation
Alice B. Kornblifh (1992)
10.1023/A:1008278725106
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients.
P. Zinzani (1997)
10.1097/00000478-199707000-00001
The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates.
M. Ashton-Key (1997)
10.1200/JCO.1993.11.2.225
Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
S. Bodis (1993)
10.1016/S0046-8177(96)90111-2
Optimal primer selection for clonality assessment by polymerase chain reaction analysis. III. Intermediate and high-grade B-cell neoplasms.
J. F. Lombardo (1996)
10.1146/ANNUREV.PSYCH.52.1.555
Health psychology: psychosocial and biobehavioral aspects of chronic disease management.
N. Schneiderman (2001)
Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
(1999)
10.1136/bmj.319.7212.731
Decision aids for patients facing health treatment or screening decisions: systematic review
A. O’Connor (1999)
10.1046/j.1365-2141.1999.01515.x
Cost‐minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B‐cell non‐Hodgkin's lymphoma in the U.K.
J. Sweetenham (1999)
10.1097/00006199-198609000-00004
Effect of preoperative instruction on postoperative outcomes: a meta-analysis.
D. Hathaway (1986)
10.1016/0360-3016(85)90096-3
Characteristics of thyroid cancer following irradiation.
A. Turrin (1985)
Neutropenic complications in advanced-stage non-Hodgkin's lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF).
N. Bobey (1998)
10.1148/RADIOLOGY.171.2.2704815
CT-guided biopsy: prospective analysis of 1,000 procedures.
T. Welch (1989)
Cost-benefit analysis of prophylactic granulocyte colonystimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma
G Dranitsaris (1997)
10.1056/NEJM199304083281404
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
R. Fisher (1993)
10.1016/S0749-0690(18)30067-3
Care of the nursing-home resident with diabetes.
M. Funnell (1999)
Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas
BD Cheson (1999)
10.1002/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I‐II non‐hodgkin's lymphomas
N. Nissen (1983)
10.1200/JCO.1999.17.2.546
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
J. Foran (1999)
10.1046/j.1365-2141.1998.00941.x
Conservative management of follicular non‐Hodgkin's lymphoma in childhood
Atra (1998)
10.1001/ARCHDERM.1987.01660260071016
Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides).
J. F. Kessler (1987)
10.1093/OXFORDJOURNALS.ANNONC.A059156
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
D. A. Stewart (1995)
Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
P. Heald (1989)
10.1200/JCO.1987.5.6.867
Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen.
P. Mclaughlin (1987)
10.1200/JCO.1999.17.4.1254
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients.
P. Zinzani (1999)
Organization and operation of a hemathology laboratory
D M Knowles (2001)
Classification of Tumours; Tumours of Haematopoietic and Lymphoid Tissues
N L Harris (2001)
Clinical and metabolic efficacy of glutaminesupplemented parenteral nutrition after bone marrow transplantation. A randomized, doubleblind, controlled study
T R Ziegler (1992)
10.1097/00002030-200108170-00005
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
A. Antinori (2001)
10.1016/S0190-9622(96)90118-8
Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy.
J. Zic (1996)
13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
K. Thomsen (1984)
10.1111/j.1600-0609.1987.tb01160.x
Protein loss during acute graft‐versus‐host disease: Diagnostic and clinical significance
H. F. Guiot (1987)
10.1002/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M
The role of recombinant interferon alfa‐2a in the therapy of cutaneous t‐cell lymphomas
P. Bunn (1986)
10.1002/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R
B‐lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology
R. Soslow (1999)
10.1016/S1278-3218(98)89073-2
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
M. Weiner (1997)
10.1200/JCO.1989.7.3.295
Male fertility following cancer chemotherapy.
R. Schilsky (1989)
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
G. Canellos (1996)
10.1034/j.1600-0609.2000.9c119.x
Deafness from eighth cranial nerve involvement in a patient with large‐cell transformation of mycosis fungoides
S. Chua (2000)
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
R. Haas (1996)
10.1002/1097-0142(19900301)65:5<1155::AID-CNCR2820650521>3.0.CO;2-7
A meta‐analysis of stages I and II Hodgkin's disease
T. Shore (1990)
10.1111/j.1440-1827.1990.tb01587.x
Hashimoto's Thyroiditis as a Risk Factor of Thyroid Lymphoma
K. Aozasa (1990)
10.1200/JCO.1998.16.12.3803
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
I. Khouri (1998)
10.1016/S0889-8588(18)30052-2
Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.
H. Koh (1995)
10.1093/OXFORDJOURNALS.ANNONC.A058153
Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP.
S. Pavlovsky (1992)
10.1016/S0140-6736(05)62067-3
Extracorporeal photopheresis in Sézary syndrome
R. Russelljones (1997)
10.1182/BLOOD.V97.11.3370
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
C. Patte (2001)
10.1056/NEJM199502163320701
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease.
T. Mack (1995)
10.1080/01635589709514535
Diet and risk of lymphoid neoplasms and soft tissue sarcomas.
A. Tavani (1997)
10.1093/OXFORDJOURNALS.ANNONC.A058293
Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.
C. Dumontet (1992)
Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences.
T. Greiner (1995)
10.1016/0360-3016(83)90321-8
Palliative radiation treatment of cutaneous mycosis fungoides--a dose response.
G. Cotter (1983)
10.1016/0959-8049(92)90017-V
Radiation therapy in clinical stage I and II Hodgkin's disease. The Princess Margaret Hospital Lymphoma Group.
M. Gospodarowicz (1992)
10.1016/0958-3947(89)90007-1
A dosimetric comparison of three compensator design methods for the mantle field.
J. Cantwell (1989)
10.1097/00000372-199910000-00019
How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides?
R. Bergman (1999)
Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia.
C. Bernasconi (1990)
10.1038/modpathol.3880336
Fine-Needle Aspiration Biopsy in the Diagnosis and Classification of Primary and Recurrent Lymphoma: A Retrospective Analysis of the Utility of Cytomorphology and Flow Cytometry
H. Dong (2001)
10.1001/jama.275.17.1315
Diet and risk of non-Hodgkin lymphoma in older women.
B. C. Chiu (1996)
10.1093/OXFORDJOURNALS.AJE.A008751
Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS)
H. Armenian (1996)
A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy.
B. Rotoli (1994)
10.1016/0167-8140(96)01715-X
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
M. Barton (1996)
10.3171/JNS.1986.65.5.0600
Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.
K. Murray (1986)
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
M. Duvic (2001)
10.1034/j.1399-3062.2001.003002070.x
Identifying the patient at risk for post‐transplant lymphoproliferative disorder
S. Cockfield (2001)
10.1002/HON.2900010209
Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative method
R. Mann (1983)
10.1200/JCO.1986.4.10.1470
Follicular lymphoma: prognostic factors for response and survival.
C. Gallagher (1986)
Aggressive lymphoma 233
Isotretinoin and cutaneous T cell lymphoma
J F Kessler (1987)
10.1182/BLOOD.V91.3.756.756_756_763
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
S. Slavin (1998)
Interactions between herbal medicines and prescribed drugs: a systematic review.
A. Izzo (2001)
10.1016/S0360-3016(01)01626-1
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment.
T. Girinsky (2001)
Lymph nodes. Manual and atlas of fine needle aspiration cytology
S R Orell (1992)
Primary and secondary Ki-1+ (CD30+) anaplastic large cell lymphoma
P Kaudewitz (1989)
Chemotherapy: toxicity management. Cancer nursing. Principles and practice. Third edn
D Camp-Sorrell (1993)
An ECOG randomized phase III trial of CHOP vs CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL)
J Glick (1995)
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries
(2001)
10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T
Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data
S. Glaser (1997)
10.1148/RADIOLOGY.190.3.8115624
Impact of positive findings at image-guided biopsy of lymphoma on patient care: evaluation of clinical history, needle size, and pathologic findings on biopsy performance.
S. Silverman (1994)
10.1002/(SICI)1096-911X(200002)34:2<92::AID-MPO3>3.0.CO;2-Q
Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
C. Bennett (2000)
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
C. Hoh (1997)
10.1080/00313029400169621
Southern Blot Analysis Of Lymphoproliferative Disorders: Use and limitations in routine surgical pathology
D. Spagnolo (1994)
Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.
M. Henry-Amar (1991)
10.1046/J.1523-5394.1999.74009.X
The low-bacteria diet for immunocompromised patients. Reasonable prudence or clinical superstition?
J. Todd (1999)
10.1182/BLOOD.V98.5.1298
Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response.
A. V. Evans (2001)
The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies.
E. Devine (1995)
10.1111/J.1445-5994.1988.TB00125.X
Improved treatment results for lymphoblastic lymphoma in adolescents and adults using a doxorubicin-based (APO) protocol.
K. Bradstock (1988)
10.1023/A:1008202808144
Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center.
R. Bouabdallah (1998)
10.1177/107155769900600502
Preservation of Fertility and Ovarian Function and Minimizing Chemotherapy-Induced Gonadotoxicity in Young Women
Z. Blumenfeld (1999)
10.1097/00007890-200104270-00010
RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1
V. Dharnidharka (2001)
10.1200/JCO.1993.11.5.989
Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients.
S. Dunn (1993)
10.1111/j.1365-2230.1978.tb01517.x
Photochemotherapy in mycosis fungoides
S. Bleehen (1978)
10.1136/JCP.54.7.565
The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders.
A. Langerak (2001)
10.3109/10428199909145947
Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.
S. Jerjis (1999)
10.1046/j.1365-2141.1997.3523168.x
Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes
S. Bolam (1997)
10.1200/JCO.1994.12.7.1358
High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.
J. Sweetenham (1994)
10.1037//0022-006X.59.4.518
Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions.
T. Burish (1991)
10.1016/S0190-9622(00)90007-0
Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin.
U. Wollina (2000)
10.1111/J.2044-8260.1986.TB00679.X
Communication variables in the design of pre-surgical preparatory information.
L. M. Wallace (1986)
10.1016/S0140-6736(05)80084-4
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
G. Opelz (1993)
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
C. Paya (1999)
10.1038/sj.bmt.1701400
High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience
N. Milpied (1998)
10.1002/1097-0142(19891115)64:10<2045::AID-CNCR2820641013>3.0.CO;2-H
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral Versus partial parenteral plus enteral nutrition
P. Mulder (1989)
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.
T. Haque (1998)
10.1093/ANNONC/2.SUPPL_2.55
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
S. Viviani (1991)
10.1200/JCO.1991.9.6.906
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
D. Longo (1991)
10.1016/0046-8177(94)90085-X
Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas.
G. Segal (1994)
10.1182/BLOOD.V39.6.874.874
Macroglobulinemia: an analysis for forty patients.
M. Mackenzie (1972)
10.1016/S0889-8588(18)30104-7
Bcl-2: prevention of apoptosis as a mechanism of drug resistance.
John Calvin Reed (1995)
311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides
A Hofer (1999)
Application of molecular genetics to the diagnosis and classification of malignant lymphoma
J Cossman (2001)
10.1055/S-2008-1074763
Complications of Abdominal and Retroperitoneal Biopsy
A. Watkinson (1994)
10.1002/PON.2960040105
Eysenck personality inventory L‐scores in patients with Hodgkin's disease and non‐Hodgkin's lymphoma
Marcia A. Ratcliffe (1995)
10.1007/978-3-642-80829-6_19
Staging laparotomy and splenectomy in Hodgkin's disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients.
H. Kaplan (1973)
Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.
H. Prince (2001)
Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
B. Nashan (1999)
10.5694/J.1326-5377.1997.TB123246.X
Safety issues in herbal medicine: implications for the health professions
A. Drew (1997)
10.1016/s0190-9622(94)70045-1
Lymphomatoid papulosis.
D. Karp (1994)
10.1093/ANNONC/9.SUPPL_5.S31
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
T. Ruediger (1998)
10.1006/BCMD.2000.0372
Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo.
C. Schmitt (2001)
10.1016/0360-3016(94)90222-4
Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution.
G. Biti (1994)
Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
M. Møller (1999)
10.1136/bmj.317.7152.180
Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study
E. Baecklund (1998)
10.1001/JAMA.279.13.1005
A close look at therapeutic touch.
L. Rosa (1998)
10.1309/MN6J-4NJY-C5CG-1PLH
The accuracy of combined cytopathologic and flow cytometric analysis of fine-needle aspirates of lymph nodes.
T. Nicol (2000)
10.1148/108.3.675
Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas.
Z. Fuks (1973)
10.1016/S0968-6053(00)80051-4
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
N. Harris (1994)
10.1016/S0140-6736(88)90367-4
UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS
A. Stansfeld (1988)
10.1200/JCO.1998.16.8.2817
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
I. Khouri (1998)
10.1200/JCO.1996.14.5.1457
Psychologic and neuropsychologic impact of autologous bone marrow transplantation.
T. Ahles (1996)
10.1182/BLOOD.V98.1.165
Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations.
A. Langerak (2001)
10.1111/J.1365-2354.1994.TB00029.X
Beyond cancer: changes, problems and needs expressed by adult lymphoma survivors attending an out-patients clinic.
L. Wallwork (1994)
10.1111/j.1365-2559.1995.tb01434.x
The polymerase chain reaction in histopathology
L. Pan (1995)
10.1038/35000501
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh (2000)
10.1007/s002590000323
Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography
T. Klose (2000)
10.1002/1096-8652(200007)64:3<175::AID-AJH6>3.0.CO;2-7
Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large‐cell lymphoma of the stomach
H. Liu (2000)
10.1200/JCO.1999.17.3.776
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
V. Diehl (1999)
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
J. Colgan (1994)
10.1182/BLOOD.V96.3.852.015K28_852_858
patients with the description of a new scoring system and its validation on 253 other patients.
P. Morel (2000)
Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women.
S. Zhang (2000)
10.1016/0360-3016(92)90538-S
Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.
D. Nelson (1992)
10.1182/BLOOD.V90.10.4201
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
L. F. Verdonck (1997)
10.1086/514579
Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.
S. Keay (1998)
10.7326/0003-4819-131-6-199909210-00003
Use of Complementary Therapies for Arthritis among Patients of Rheumatologists
J. Rao (1999)
Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation.
R. Chatterjee (1996)
10.1097/00007890-199904150-00021
Intestinal transplantation: 1997 report of the international registry. Intestinal Transplant Registry.
D. Grant (1999)
10.1038/sj.bmt.1703160
Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies
R. Chatterjee (2001)
10.1056/NEJM199910073411501
Body-mass index and mortality in a prospective cohort of U.S. adults.
E. Calle (1999)
Immunohistochemical analysis of lymphoid tissue
R A Warnke (2001)
A randomized controlled trial of psychotherapeutic intervention in cancer patients
A Ilnyckyj (1994)
Predictive value of the combination of TNF-alpha low and IL-10 low producer genotypes and high EBV virus load for the development of PTLD in solid organ transplant recipients
N Babel (2000)
CHOP v CHOP + radiotherapy (RT) for limited-stage diffuse aggressive lymphoma
S J Horning (2001)
Mortality and cancer incidence in 263 patients with ataxiatelangiectasia
D Morrell (1986)
10.1056/NEJM198702053160603
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.
R. Edelson (1987)
10.1046/j.1365-2559.2001.01039.x
Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria
D. Canioni (2001)
10.7326/0003-4819-122-10-199505150-00006
Eradication of Helicobacter pylori Infection in Primary Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue
E. Roggero (1995)
10.1111/j.1600-065X.1999.tb01328.x
Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation
R. Khanna (1999)
Management of high-grade lymphomas.
I. Magrath (1998)
Impact of patient weight on non-relapse mortality after marrow transplantation.
H. Deeg (1995)
10.1002/1097-0142(19820301)49:5<1048::AID-CNCR2820490534>3.0.CO;2-G
Effects of counseling for late stage cancer patients
M. Linn (1982)
The Surfers Paradise Safety Action Project (January 1993-June 1994): Evaluation report for the Commonwealth Department of Health and Family Services
R. Homel (1996)
10.1200/JCO.2000.18.3.487
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
F. V. van Leeuwen (2000)
10.1038/sj.bmt.1702391
Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies
R. Chatterjee (2000)
10.1038/sj.leu.2402161
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen
R. Smalley (2001)
10.1007/BF02990087
A British national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapyversus radiotherapy alone in low grade, localised non-hodgkins Lymphoma
S. Kelsey (1994)
10.1007/s004390000291
A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden
Y. Shugart (2000)
10.1056/NEJM199311253292203
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
P. Solal-Céligny (1993)
10.1016/S0360-3016(97)00553-1
Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides).
L. Wilson (1998)
10.1093/AJE/153.11.1056
Vitamin supplement use and the risk of non-Hodgkin's lymphoma among women and men.
S. Zhang (2001)
10.1200/JCO.1995.13.4.969
Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.
C. Bennett (1995)
Strategies for managing cancer-related fatigue syndrome a rehabilitation approach
S. Kirshblum (2001)
10.1097/00019606-199209000-00003
A Simplified Method of Detection of Clonal Rearrangements of the T‐Cell Receptor-γ Chain Gene
K. Mccarthy (1992)
10.1056/NEJM199211053271902
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
R. Smalley (1992)
10.1002/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
O. Neth (2000)
10.1093/JNCI/76.2.359
Prematurity and risk of childhood cancer.
C. Johnson (1986)
10.1200/JCO.1999.17.8.2486
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
B. Nathwani (1999)
10.1200/JCO.1991.9.1.123
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
C. Patte (1991)
10.1182/BLOOD.V94.10.3294.422K12_3294_3306
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
A. Reiter (1999)
Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).
G. Santini (1989)
10.1200/JCO.1998.16.5.1916
Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone.
N. Schechter (1998)
10.1016/S0190-9622(96)90119-X
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
S. Gottlieb (1996)
10.1002/(SICI)1096-911X(199712)29:6<526::AID-MPO2>3.0.CO;2-M
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.
M. Brecher (1997)
[Breast cancer after treatment of Hodgkin's disease].
J. Lévêque (1995)
10.1046/J.1440-1673.2001.00930.X
Management of localized low-grade follicular lymphomas.
M. MacManus (2001)
10.1111/J.1445-5994.1998.TB04456.X
Comparison of thallium-201 and gallium-67 scintigraphy in the evaluation of non-Hodgkin's lymphoma.
P. Roach (1998)
10.1038/bjc.1991.347
Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study.
C. Stiller (1991)
10.1002/1097-0142(19811001)48:7<1508::AID-CNCR2820480704>3.0.CO;2-F
Childhood non‐hodgkin's lymphoma: Long‐term results of an intensive chemotherapy regimen
M. Gasparini (1981)
10.1016/S0360-3016(01)01549-8
Stage I and II MALT lymphoma: results of treatment with radiotherapy.
R. Tsang (2001)
10.1016/0002-9343(94)90043-4
Clinical characteristics of post-transplant lymphoproliferative disorders.
V. Morrison (1994)
10.1016/S0041-1345(00)02700-7
A gene polymorphism associated with posttransplant lymphoproliferative disorder.
A. Vanbuskirk (2001)
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.
(1982)
10.1182/blood.v89.11.3909
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.
J. Armitage (1997)
10.1016/S0360-3016(97)00127-2
Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
P. Quiros (1997)
10.1309/VF28-E64G-1DND-LF94
Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate.
D. Menke (2000)
10.1023/A:1011136324038
Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.
M. Sandherr (2001)
10.1016/S0140-6736(75)91142-3
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE: RESULTS WITH COMBINATION CHEMOTHERAPY
V. Devita (1975)
10.1046/j.1365-2141.1999.01422.x
Syngeneic stem cell transplantation for HIV‐related lymphoma
P. Campbell (1999)
Polymerase chain reaction in the assessment of lymphomas.
T. Diss (1997)
Complementary and alternative medicine: the role of the cancer center.
K. Antman (2001)
10.1016/S0190-9622(96)80062-4
Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients.
H. Zackheim (1996)
Lymphoproliferative disorders associated with congenital immunodeficiencies.
K. S. Elenitoba-Johnson (1997)
10.5694/j.1326-5377.2001.tb143462.x
A primer of complementary and alternative medicine commonly used by cancer patients
G. Mendelson (2001)



This paper is referenced by
10.1016/j.pain.2009.01.013
Excessive opioid use and the development of chronic migraine
M. Bigal (2009)
Are guidelines ethical? Some considerations for general practice.
W. Rogers (2002)
10.1136/jech-2015-205708
Commentary on “Are fluoride levels in drinking water associated with hypothyroidism prevalence in England? A large observational study of GP practice data and fluoride levels in drinking water”
D. Grimes (2015)
Farmakoterapia wyprysku atopowego - analiza rozbieżności między wytycznymi ekspertów, dokumentami rejestracyjnymi i dowodami skuteczności rekomendowanych leków Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence f
K. Kordus (2013)
10.1002/cre2.134
Perceived oral health in patients after bariatric surgery using oral health‐related quality of life measures
L. Karlsson (2018)
10.1016/S0034-9356(12)70002-6
Consideraciones preoperatorias y manejo neuroanestesiológico intraoperatorio
F. Clavero (2012)
10.20381/RUOR-282
Exploring the Abortion Experiences of Punjabi Women in Canada: A Qualitative Study
Prabjyot Kaur Chahil (2016)
10.1016/j.jhep.2013.11.003
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
A. Aghemo (2014)
10.1177/1129729819848624
Quality assessment of vascular access procedures for hemodialysis: A position paper of the Vascular Access Society based on the analysis of existing guidelines
Branko Fila (2019)
10.1007/s11136-016-1405-4
Dutch normative data and psychometric properties for the Distress Thermometer for Parents
H. V. van Oers (2016)
10.1186/s12904-016-0100-0
To what degree is palliative care integrated in guidelines and pathways for adult cancer patients in Europe: a systematic literature review
K. van Beek (2016)
A study exploring the relationships between diabetic foot ulcer pain and health-related quality of life and functional status of people aged sixty years and over in Malaysia
A. Makhtar (2016)
10.1080/17538150902865136
Clinical guidelines about diabetes and the accuracy of peer information in an unmoderated online health forum for retired persons
L. Hoffman-Goetz (2009)
10.3389/fonc.2020.551255
A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
L. Peng (2020)
10.18553/JMCP.2014.20.11.1129
Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
Sara C. Erickson (2014)
10.7573/dic.212586
Use of botulinum toxin for movement disorders
C. H. Camargo (2019)
10.1007/s00270-013-0795-8
Repeated Intra-Arterial Therapy via the Cystic Artery for Hepatocellular Carcinoma
Hee Ho Chu (2013)
10.1007/s40618-017-0706-y
Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report
M. Centanni (2017)
Strategies to address auditory perceptual deficits in a school of skills in the northern suburbs of Cape Town
Jacqueline Jacobs (2016)
10.1080/10913670701294062
Assessing the Validity of a Stage Measure on Physical Activity in a Population-Based Sample of Individuals With Type 1 or Type 2 Diabetes
R. Plotnikoff (2007)
10.1016/S0212-6567(02)79102-6
Efectividad a medio plazo de un plan de ayuda al fumador desarrollado en atención primaria
M. A. Fernández (2002)
10.1016/S1134-282X(01)77405-2
Las vías clínicas basadas en la evidencia como estrategia para la mejora de la calidad: metodología, ventajas y limitaciones
G. Carrasco (2001)
10.11124/jbisrir-2011-352
Venous Thromboembolism (VTE) Risk Assessment and Prophylaxis: A Comprehensive Systematic Review of the Facilitators and Barriers to Healthcare Worker Compliance with Clinical Practice Guidelines in the Acute Care Setting
S. Gaston (2012)
10.1007/s12020-018-1798-7
l-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia
Elisabetta Morini (2018)
10.1159/000489923
Salvage of Hemodialysis Catheter in Staphylococcal Bacteremia: Case Series, Revisiting the Literature, and the Role of the Pharmacist
W. E. El Nekidy (2018)
10.1186/1471-2458-13-8
Epidemiology of smoking among Malaysian adult males: prevalence and associated factors
Hock kuang Lim (2013)
10.3109/10398569809084869
Clinical Practice Guidelines and Clinical Pathways: Defining the Tasks and the Implications for Public Sector Mental Health Systems
M. Tobin (1998)
Bone resorption marker status of pre and postmenopausal malay women in Kelantan and its corresponding risk factors
Hermizi Hapidin (2013)
10.1016/J.METABOL.2004.11.010
Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging.
A. Rodriguez (2005)
10.1080/14753630410001733985
A review of the evolution of research evidence and activity for NHS primary care counselling
J. Mellor-Clark (2004)
Alcohol Use Disorder and Withdrawal Syndrome in Correctional Facilities: An Evidence-Based Clinical Practice Guideline to Prevent Alcohol-Related Adverse Events
Wanda Wilma González-Méndez (2017)
Assessment Of Nurse's Knowledge Concerning Glasgow Coma Scale In Neuro Surgical Wards
Batool A. Jaddoua (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar